These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15754617)

  • 1. Repeated intervals of high-dose corticosteroid: an overlooked therapy in multiple sclerosis.
    Johnson LN; Morey SS
    Mo Med; 2005; 102(1):47-50. PubMed ID: 15754617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving management of optic neuritis and multiple sclerosis.
    Arnold AC
    Am J Ophthalmol; 2005 Jun; 139(6):1101-8. PubMed ID: 15953446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
    Schwid SR; Panitch HS
    Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic neuritis.
    Dorfman L
    N Engl J Med; 2006 Jul; 355(2):212; author reply 212. PubMed ID: 16837690
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of optic neuritis].
    van der Worp HB; van Gijn J; Plant GT
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):61-5. PubMed ID: 14753126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis.
    Motamed MR; Najimi N; Fereshtehnejad SM
    Clin Neurol Neurosurg; 2007 May; 109(4):344-9. PubMed ID: 17300863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Optic neuritis.
    Balcer LJ
    N Engl J Med; 2006 Mar; 354(12):1273-80. PubMed ID: 16554529
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for early treatment trials in patients presenting with clinical and paraclinical abnormalities which put them at high risk for conversion to multiple sclerosis. European Charcot Foundation Working Group for Treatment Trials.
    Mult Scler; 1995; 1 Suppl 1():S55-9. PubMed ID: 9345401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group.
    Beck RW; Trobe JD
    J Neuroophthalmol; 1995 Sep; 15(3):131-5. PubMed ID: 8574355
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
    Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
    Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS study.
    Freedman MS; Forrestal FG
    Mult Scler; 2008 Nov; 14(9):1234-41. PubMed ID: 18632774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
    Kinkel RP; Kollman C; O'Connor P; Murray TJ; Simon J; Arnold D; Bakshi R; Weinstock-Gutman B; Brod S; Cooper J; Duquette P; Eggenberger E; Felton W; Fox R; Freedman M; Galetta S; Goodman A; Guarnaccia J; Hashimoto S; Horowitz S; Javerbaum J; Kasper L; Kaufman M; Kerson L; Mass M; Rammohan K; Reiss M; Rolak L; Rose J; Scott T; Selhorst J; Shin R; Smith C; Stuart W; Thurston S; Wall M;
    Neurology; 2006 Mar; 66(5):678-84. PubMed ID: 16436649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic neuritis treatment trial:10-year follow-up results.
    Chan CK; Lam DS
    Am J Ophthalmol; 2004 Oct; 138(4):695; author reply 695. PubMed ID: 15488834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk].
    Dtsch Med Wochenschr; 1994 Jun; 119(24):897. PubMed ID: 8005072
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMS.
    Francis GS; Rice GP; Alsop JC;
    Neurology; 2005 Jul; 65(1):48-55. PubMed ID: 16009884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute demyelinating optic neuritis.
    Balcer LJ; Galetta SL
    Semin Ophthalmol; 2002 Mar; 17(1):4-10. PubMed ID: 15513449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
    Schwid SR; Thorpe J; Sharief M; Sandberg-Wollheim M; Rammohan K; Wendt J; Panitch H; Goodin D; Li D; Chang P; Francis G; ;
    Arch Neurol; 2005 May; 62(5):785-92. PubMed ID: 15883267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.